Bioventus annual gross profit
2019
2020
2021
2022
2023
2024
2025
Bioventus Gross Profit Growth & History (BVS)
Bioventus's gross profit was $388.2M for fiscal 2025.
View full Bioventus company overviewBioventus annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $388.2M | −$69,000 | −0.02% |
| 2024 | 2024-12-31 | $388.2M | $60.0M | +18.29% |
| 2023 | 2023-12-31 | $328.2M | −$2.9M | −0.87% |
| 2022 | 2022-12-31 | $331.1M | $28.4M | +9.37% |
| 2021 | 2021-12-31 | $302.7M | $69.2M | +29.63% |
| 2020 | 2020-12-31 | $233.5M | −$15.7M | −6.29% |
| 2019 | 2019-12-31 | $249.2M | — | — |
Bioventus quarterly gross profit
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-27 | $105.7M | $3.6M | +3.50% |
| Q1 2026 | 2026-03-28 | $90.8M | $7.7M | +9.29% |
| Q4 2025 | 2025-12-31 | $108.8M | $6.1M | +5.97% |
| Q3 2025 | 2025-09-27 | $94.2M | $678,000 | +0.72% |
| Q2 2025 | 2025-06-28 | $102.1M | −$1.5M | −1.49% |
| Q1 2025 | 2025-03-29 | $83.1M | −$5.3M | −6.02% |
| Q4 2024 | 2024-12-31 | $102.7M | $16.4M | +18.95% |
| Q3 2024 | 2024-09-28 | $93.6M | $14.7M | +18.64% |
| Q2 2024 | 2024-06-29 | $103.6M | $14.5M | +16.29% |
| Q1 2024 | 2024-03-30 | $88.4M | $14.5M | +19.56% |
| Q4 2023 | 2023-12-31 | $86.3M | $12.1M | +16.33% |
| Q3 2023 | 2023-09-30 | $78.8M | −$5.7M | −6.73% |
| Q2 2023 | 2023-07-01 | $89.1M | −$7.5M | −7.79% |
| Q1 2023 | 2023-04-01 | $73.9M | −$1.8M | −2.36% |
| Q4 2022 | 2022-12-31 | $74.2M | −$13.6M | −15.47% |
| Q3 2022 | 2022-10-01 | $84.5M | $5.5M | +6.91% |
| Q2 2022 | 2022-07-02 | $96.7M | $20.3M | +26.65% |
| Q1 2022 | 2022-04-02 | $75.7M | $16.1M | +27.11% |
| Q4 2021 | 2021-12-31 | $87.8M | $14.3M | +19.46% |
| Q3 2021 | 2021-10-02 | $79.1M | $16.6M | +26.58% |
| Q2 2021 | 2021-07-03 | $76.3M | $36.0M | +89.13% |
| Q1 2021 | 2021-04-03 | $59.6M | $2.3M | +4.05% |
| Q4 2020 | 2020-12-31 | $73.5M | — | — |
| Q3 2020 | 2020-09-26 | $62.5M | — | — |
| Q2 2020 | 2020-06-27 | $40.3M | — | — |
| Q1 2020 | 2020-03-28 | $57.2M | — | — |
Bioventus gross profit trends
Over the last five fiscal years, Bioventus's gross profit increased from $233.5M to $388.2M, a change of $154.6M. The latest reported quarter, Q2 2026, shows $105.7M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus source filings ↗